广东凌霄泵业股份有限公司 投资者关系活动记录表 证券代码：002884 证券简称：凌霄泵业 广东凌霄泵业股份有限公司投资者关系活动记录表 编号：TX【2025003】 投资者关系活 动类别 □特定对象调研 □分析师会议 □媒体采访 ☑业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 参与单位名称 及人员姓名 投资者网上提问 时间 2025 年 4 月 18 日 (周五 下午 15:00~17:00） 地点 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） 采用网络远程的方式召开业绩说明会 上市公司接待 人员姓名 1、董事长、总经理王海波 2、董事、董事会秘书刘子庚 3、财务总监陆凤娟 4、独立董事苏文卿 投资者关系活 动主要内容介 绍 一、问答环节： 1."请问：1、2024 年公司对美国客户以及通过渠道商最终销往 美国的产品销售额是多少？销售毛利率是多少？2、对美国销售额 2025 年基本上会归零吗？3、公司如何应对中美贸易战带来的影 响？ 尊敬的投资者，您好，根据公司 2024 年年度报告，公司出口 业务占公司总应收的 53%，出口毛利率为 39.13%，主要出口美洲、 ...

证券代码：300529 证券简称：健帆生物 债券代码：123117 债券简称：健帆转债 健帆生物科技集团股份有限公司 答：您好。公司近年的在建工程投向主要是珠海健树生物材料（高附加值 树脂等核心原材料）项目、医疗器械产业（血液净化）项目，以及在智能制造、 精益生产和自动化改造方面的投入。随着未来收入规模的提高，公司的前瞻性 生产布局规划，有利于进一步发挥规模及成本优势，确保公司产品安全供应， 提升市场份额，巩固公司市场领先地位。感谢您的关注！ 问题 3：贵公司自从去年提出市值管理的口号后股价已经累计下跌了约 30%。请问贵公司的市值管理是什么？如何具体实施？是否会考虑投资者的利 益？如果真的考虑中小投资者的利益，那么一季报显示账面上的 21 亿理财资 金是否可以拿出一部分用来回购注销公司的股份，用实际行动来回报信任公司 的中小投资者？？ 答：您好。（1）感谢您的建议，公司将综合发展战略、经营情况及股价等 多方面因素，充分考虑您的建议，如有相关计划，公司将及时履行信息披露义 务，请您关注公司公告。（2）购买理财产品旨在提高暂时闲置资金的使用效率， 为股东谋取更多的投资回报，我们对公司未来发展保持信心。（3）公司 ...

Group 1: Financial Performance - In 2024, the company achieved a revenue of 4.91 billion yuan, representing a year-on-year growth of 18.64% [2] - Revenue from new energy-related businesses reached 2.23 billion yuan, accounting for 45.46% of total revenue, an increase of 14.32% [2] Group 2: Product Advantages - The company's self-developed reverse planetary roller screw products feature core advantages of "high load, high precision, and long lifespan," significantly enhancing load capacity, speed, and lifespan while reducing production costs [3] - The acquisition of Wuxi Kezhixin Machinery Technology Co., Ltd. has strengthened the company's capabilities across the entire industry chain, from "materials-design-processing-testing" [3] Group 3: Strategic Acquisitions - The acquisition of Kezhixin completed a key piece in the humanoid robot screw industry chain, with its internal thread grinding technology being a critical asset [4] - The reverse planetary roller screw grinding machine developed by Kezhixin can reduce the cost of a single device from tens of millions to 3 million yuan, while compressing delivery time by 75% [4] Group 4: International Expansion - The new Torch Thailand factory has established three high-end hub bearing production lines, achieving localized production with products certified by U.S. customs [5] - The Thailand factory commenced mass production in January 2025, with products being delivered, and is expected to achieve small batch production of OEM qualified products by June 2025 [5]

证券代码：002294 证券简称：信立泰 深圳信立泰药业股份有限公司投资者关系活动记录表 编号：20250418 | | □特定对象调研 □分析师会议 | | --- | --- | | 投 资 者 关 | □媒体采访 √业绩说明会 | | 系 活 动 类 | □新闻发布会 □路演活动 | | 别 | □现场参观 □电话会议 | | | □其他（请文字说明其他活动内容） | | 活 动 参 与 | 全体投资者 | | 人员 | | | 时间 | 2025 年 4 月 18 日 15:00-17:00 | | | 深圳证券交易所"互动易平台"http://irm.cninfo.com.cn"云访谈" | | 地点 | 栏目 | | 形式 | 网络远程方式 | | 上 市 公 司 | | | 接 待 人 员 | 董事、董事会秘书：杨健锋；财务负责人：孔芸 | | 姓名 | | | | 首先，杨健锋先生对公司情况进行了介绍；然后公司参会领 | | | 导对投资者关注的问题进行了回复。 | | 投 资 者 关 | | | | 1.尊敬杨总：信立坦 2024 年销售额 15 亿元（占营收 37.4%）， | | 系 活 ...

证券代码：301121 证券简称：紫建电子 重庆市紫建电子股份有限公司 2024 年度业绩说明会投资者活动记录表 编号：2025-001 顺应行业变化、满足市场客户需求，产品收入构成占比日渐合理；同 时，公司不断提升技术研发和创新能力，为进一步提升产品的价值空 间和市场竞争力创造条件。在成本端，原材料价格向下调整，相对更 加稳定，公司也持续在降本增效和自动化率上采取有效措施，从而进 一步提升毛利率。 四、在新兴消费电子领域，公司认为后续的增长主要来自哪里？ 答：尊敬的投资者，您好！感谢您对公司的关注和支持！随着生 成式人工智能的迅速普及和商业化应用，新业态、新应用、新需求持 续涌现，促进终端智能交互升级和硬件设备增长，引发消费电子市场 新一轮创新热潮，锂离子电池作为新兴消费类电子产品的重要组成部 分，也将直接受益于新兴消费类电子产品市场的快速发展保持持续增 长。现有产品的良性增长，TWS耳机主要依托智能手机品牌的主导，但 高性价比品牌与细分市场创新也为消费者提供了更多的选择空间。随 着科技的飞速发展，智能可穿戴设备已经成为人们日常生活中不可或 缺的一部分，尤其是腕戴设备，如智能手表和手环，更是凭借其便捷 性、 ...

Group 1: Investor Relations Activity Overview - The company held an earnings briefing on April 17, 2025, from 15:00 to 17:00 via an online platform [3] - Participants included investors attending remotely, with key company representatives such as the Chairman and General Manager present [3] Group 2: Company Performance and Strategic Responses - The company is addressing the impact of overcapacity in the photovoltaic industry by expanding its business model from EPC services to include power station development, operation, and sales [5] - The acquisition of a 47% stake in Zhongxin Xude has positioned the company to enhance its operational capabilities and expand its market reach [5] - The company plans to maintain steady growth in its prefabricated construction business while accelerating the development of its photovoltaic new energy sector [6] Group 3: International Expansion and Market Strategy - The company aims to leverage its experience in Australia to expand into emerging markets in the Middle East and Africa, establishing a subsidiary in Dubai to enhance its international competitiveness [6] - The strategic focus includes developing a closed-loop system for distributed photovoltaic power stations, which will improve operational efficiency and revenue generation [6]

证券代码：000833 证券简称：粤桂股份 编号：2025-001 广西粤桂广业控股股份有限公司 投资者活动记录表 | | □特定对象调研 | □分析师会议 | | --- | --- | --- | | 投资者关系活 | □媒体采访 | √业绩说明会 | | 动类别 | □新闻发布会 | □路演活动 | | | □现场参观 | □电话会议 | | | □其他： （请文字说明其他活动内容） | | | 参与单位名称 | | | | | | 粤桂股份2024年度业绩说明会采用网络远程方式进行，面向全体投资者 | | 及人员姓名 | | | | 时间 | 2025 年 4 月 18 日 15:00-16:30 | | | 地点 | | 1.深圳证券交易所"互动易平台"http://irm.cninfo.com.cn"云访谈"栏目； | | | 2.价值在线（https://eseb.cn/1nmf8GLivkc）网络互动 主持人：粤桂股份 | | | | 董事长：刘富华 | | | | 董事、总经理：卢勇滨 | | | 公司接待人员 | 独立董事：胡咸华 | | | 姓名 | 独立董事：刘祎 | | | | 独立 ...

| 度。未来，公司将通过产品竞争力提升和市场风险分散的双 | | --- | | 重举措，推动出口业务可持续发展。谢谢！ | | 2、分析师认为钢铁行业处于周期底部，公司如何看待 | | 2025 年需求？是否会通过并购（如山东鹰轮）或减产应对 | | 市场波动？如何平衡产能利用率与利润？ | | 答：当前钢铁行业正处于周期性调整阶段，2025 年市 | | 场需求保持审慎乐观态度。随着国家"十四五"规划重大 | | 项目持续推进，以及新能源装备、汽车制造等下游行业的结 | | 构性增长，高品质特种钢领域仍将保持稳定需求。公司将以 | | 智能化改造提升生产能力，通过持续强化技术创新，提升新 | | 品开发能力，提高高端产品市场占比率。未来，公司将以 | | "高端化、智能化、绿色化"为方向，通过产品结构优化和 | | 技术升级来平衡产能与利润。谢谢！ | | 3、公司是否计划扩大高利润产品（如特种钢、汽车用 | | 钢）的产能？未来是否有新的技术突破？ | | 答：公司高度重视高利润产品的战略布局和技术创新。 | | 2024 年公司研发投入 5.82 亿元，占营收总额 4.04%。公司 | | 依托省级企 ...

Financial Performance - In 2024, the company achieved a revenue of CNY 41.906 billion, a year-on-year increase of 3.16% [4] - The net profit attributable to shareholders was CNY 3.512 billion, up 23.72% year-on-year [4] - The net profit after deducting non-recurring gains and losses was CNY 3.352 billion, reflecting a growth of 22.48% [4] - Compared to 2021, revenue and net profit grew by 21.24% and 52.59%, respectively [4] Business Segments Performance Pharmaceutical Industry - The pharmaceutical segment generated a revenue of CNY 13.811 billion, with a year-on-year growth of 13.05% [5] - The net profit for this segment was CNY 2.876 billion, increasing by 29.04% [5] - R&D investment in the pharmaceutical industry reached CNY 2.678 billion, a 16.77% increase [5] Aesthetic Medicine - The domestic aesthetic medicine subsidiary reported a revenue of CNY 1.139 billion, growing by 8.32% [6] - The UK subsidiary, Sinclair, generated approximately CNY 0.967 billion, a decline of 25.81% due to global economic challenges [6] Industrial Microbiology - The industrial microbiology segment achieved a revenue of CNY 0.711 billion, a significant increase of 43.12% [25] - Growth rates for specific areas included 38% for specialty raw materials and intermediates, 20% for xRNA, and 142% for health and biological materials [25] R&D and Product Development - The company has over 80 innovative drug candidates in its pipeline [5] - The oral small molecule GLP-1 receptor agonist HDM1002 has shown promising results in clinical trials, with over 800 participants [17] - The ADC pipeline includes more than 12 projects, with ongoing clinical trials for several candidates [14] Market Strategy and Future Outlook - The company plans to actively participate in medical insurance negotiations for new products [6] - There is a focus on expanding market presence in both domestic and international markets, particularly in the aesthetic medicine sector [26] - The company anticipates a gradual recovery in overseas aesthetic medicine markets [26] Investor Relations and Communication - The annual performance meeting was attended by 381 institutional and individual investors [2] - The chairman emphasized the commitment to high-quality development and strategic goals for the upcoming three-year plan [27]

Group 1: Company Overview and Achievements - Qinghai Salt Lake Industry Co., Ltd. is a key member of China Minmetals Corporation, leveraging the unique resource advantages of the Chaka Salt Lake for comprehensive resource development [1][2]. - The Chaka Salt Lake covers an area of 5,856 square kilometers, making it the largest soluble potassium and magnesium salt deposit in China and a significant player globally [1][2]. - The company has achieved a stable annual production capacity of 5 million tons of potassium fertilizer, ranking fourth globally, and 40,000 tons of lithium carbonate, leading the domestic brine lithium extraction sector [2][3]. Group 2: Financial Performance - In 2024, the company reported total revenue of 15.134 billion yuan and a net profit attributable to shareholders of 4.663 billion yuan [3][13]. - As of December 31, 2024, total assets reached 45.783 billion yuan, with liabilities of 6.189 billion yuan, resulting in a low debt-to-asset ratio of 13.52% [3][13]. - Shareholder equity increased by 14.63% year-on-year, amounting to 36.575 billion yuan, reflecting strong profitability and growth [3][13]. Group 3: Strategic Goals and Development Plans - The year 2025 marks a pivotal year for the company as it integrates into the China Minmetals system, aiming to accelerate the construction of a world-class salt lake industry base [4][14]. - The company plans to achieve a production capacity of 10 million tons of potassium fertilizer and 200,000 tons of lithium salt by 2030, with a vision to establish a comprehensive salt lake industry cluster by 2035 [4][20]. - The strategic development path includes focusing on one goal, adhering to three musts, and leveraging four roles to enhance competitiveness and sustainability [5][7][9]. Group 4: Operational Strategies - The company emphasizes high-quality development by leveraging China Minmetals' expertise in project investment and management to enhance production capabilities [7][8]. - It aims to implement lean management practices to optimize operations and improve efficiency, ensuring robust performance in competitive markets [7][8]. - The company is committed to addressing capability gaps by embracing digital and green technologies to enhance production quality and operational resilience [8][9]. Group 5: Risk Management and Social Responsibility - A comprehensive risk management system is in place to identify and mitigate various risks, ensuring stable operations [2][8]. - The company actively engages in social responsibility initiatives, enhancing its corporate image and contributing positively to the community [2][11]. - Safety culture is prioritized, with measures in place to ensure safe production practices and environmental protection [10][11]. Group 6: Investor Relations and Future Outlook - The company maintains close communication with investors, providing timely updates on strategic developments and performance [11][24]. - Plans for future capital management include a focus on sustainable growth and potential dividend policies as financial conditions improve [17][24]. - The company is exploring international opportunities to enhance resource acquisition and market presence, particularly in potassium fertilizer [20][24].